Related Experiment Video
Updated: Aug 8, 2025

Roux-en-Y Gastric Bypass Operation in Rats
Published on: June 11, 2012
Marginal ulcers and associated risk factors after Roux-en-Y gastric bypass
Matthew Wynn1, Kristen M Tecson2, David Provost1
1Department of Surgery, Baylor Scott & White Medical Center - Temple, Temple, Texas.
Roux-en-Y gastric bypass (RYGB) can lead to marginal ulcers. Urgent presentation with perforation increases ICU stays and hospitalization length, highlighting the need for patient counseling on this risk.
Area of Science:
- Bariatric Surgery
- Gastroenterology
- Surgical Complications
Background:
- Morbid obesity prevalence is rising, increasing Roux-en-Y gastric bypass (RYGB) popularity.
- Marginal ulceration is a known long-term risk of RYGB, potentially requiring urgent surgical intervention if perforated.
Purpose of the Study:
- To identify patient characteristics and clinical courses differentiating elective from urgent presentations of marginal ulcers post-RYGB.
- To inform surgical decision-making and patient counseling regarding RYGB complications.
Main Methods:
- Retrospective analysis of 43 patients undergoing surgery for marginal ulcers after RYGB between May 2016 and February 2021.
- Comparison of patient demographics, comorbidities, medications, and clinical outcomes between elective and urgent presentation groups.
Main Results:
- Urgent presentations (perforation) were associated with fewer bleeds and strictures compared to elective cases.
- Urgent presentations led to higher intensive care unit admission rates and significantly longer hospital stays (median 5 vs. 2 days).
- Elective cases underwent resection and reanastomosis, while urgent cases received omental patch repair.
Conclusions:
- Patients presenting urgently with perforated marginal ulcers face increased critical care needs and prolonged hospitalization.
- Bariatric surgeons should emphasize the risk of marginal ulcer perforation during patient counseling to mitigate severe outcomes.
- Early recognition and management strategies are crucial for improving outcomes in post-RYGB marginal ulcer patients.
Related Concept Videos
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.

